PMID- 8103513 OWN - NLM STAT- MEDLINE DCOM- 19931001 LR - 20171213 IS - 8750-7587 (Print) IS - 0161-7567 (Linking) VI - 74 IP - 6 DP - 1993 Jun TI - Retrotrapezoid nucleus glutamate receptors: control of CO2-sensitive phrenic and sympathetic output. PG - 2958-68 AB - In decerebrate cats, we asked whether endogenous glutamate in the region of the retrotrapezoid nucleus (RTN) was involved in the control of CO2-sensitive phrenic and phrenic-related sympathetic output and, if so, which type of glutamate receptor was predominant. We made unilateral 10-nl injections into the RTN of the nonspecific glutamate receptor antagonist kynurenic acid (100 and 250 mM), the N-methyl-D-aspartic acid (NMDA) receptor antagonist 2-amino-5-phosphonopentanoic acid (AP5; 1 and 10 mM), the non-NMDA receptor antagonist 6-cyano-7-nitroquinoxaline-2, 3-dione (CNQX; 1 and 10 mM), and the inactive kynurenic acid analogue xanthurenic acid (100 mM). Each antagonist resulted in a significant dose-dependent decrease in the amplitude of the integrated phrenic nerve signal (PNA) over 30 min (CNQX > AP5 > kynurenic acid). The duration of the phrenic cycle was also decreased because of a shortening of expiratory time (CNQX > kynurenic acid > AP5). All three antagonists significantly decreased the initial slope of the PNA response to increased CO2 by 70-80% with no clear distinction in efficacy. The amplitude of the respiratory-related integrated cervical sympathetic nerve signal (SNA) was significantly decreased after kynurenic acid and CNQX but not AP5. In each case, the decrease in respiratory-related SNA accompanied a decrease in PNA and, at high levels of CO2, the decrease in respiratory-related SNA was greater than that of PNA. Endogenous glutaminergic input to neurons in the RTN via both NMDA and non-NMDA receptors is involved in the control of eucapneic PNA and timing, PNA-related SNA, and the response to increased CO2. FAU - Nattie, E E AU - Nattie EE AD - Department of Physiology, Dartmouth Medical School, Lebanon, New Hampshire 03756-0001. FAU - Gdovin, M AU - Gdovin M FAU - Li, A AU - Li A LA - eng GR - HL-07449/HL/NHLBI NIH HHS/United States GR - HL-28066/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Appl Physiol (1985) JT - Journal of applied physiology (Bethesda, Md. : 1985) JID - 8502536 RN - 0 (Quinoxalines) RN - 0 (Receptors, Glutamate) RN - 142M471B3J (Carbon Dioxide) RN - 6OTE87SCCW (6-Cyano-7-nitroquinoxaline-2,3-dione) RN - 76726-92-6 (2-Amino-5-phosphonovalerate) RN - H030S2S85J (Kynurenic Acid) SB - IM MH - 2-Amino-5-phosphonovalerate/pharmacology MH - 6-Cyano-7-nitroquinoxaline-2,3-dione MH - Animals MH - Blood Pressure/drug effects/physiology MH - *Carbon Dioxide MH - Cats MH - Decerebrate State/physiopathology MH - Electrophysiology MH - Female MH - Kynurenic Acid/pharmacology MH - Male MH - Medulla Oblongata/anatomy & histology/*physiology MH - Phrenic Nerve/*physiology MH - Quinoxalines/pharmacology MH - Receptors, Glutamate/drug effects/*physiology MH - Respiration/drug effects/physiology MH - Sympathetic Nervous System/physiology EDAT- 1993/06/01 00:00 MHDA- 1993/06/01 00:01 CRDT- 1993/06/01 00:00 PHST- 1993/06/01 00:00 [pubmed] PHST- 1993/06/01 00:01 [medline] PHST- 1993/06/01 00:00 [entrez] AID - 10.1152/jappl.1993.74.6.2958 [doi] PST - ppublish SO - J Appl Physiol (1985). 1993 Jun;74(6):2958-68. doi: 10.1152/jappl.1993.74.6.2958.